Accelerated Approval Standards Will Be Advisory Committee Topic In March
Executive Summary
FDA is planning an advisory committee meeting to discuss the accelerated approval process for oncologic agents
You may also be interested in...
Cancer Drug Confirmatory Trials Should Be Initiated Early, FDA Says
FDA is urging sponsors of cancer drugs undergoing accelerated approval to initiate confirmatory studies early to avoid problems in completing trials often seen after approval
Accelerated Approval Needs Enforcement Mechanism For Confirmatory Trials
FDA needs to create an enforcement mechanism to ensure that companies with anticancer agents awarded accelerated approval complete confirmatory trials to show actual clinical benefit, the Oncologic Drugs Advisory Committee agreed
Cancer Drug Confirmatory Trials Should Be Initiated Early, FDA Says
FDA is urging sponsors of cancer drugs undergoing accelerated approval to initiate confirmatory studies early to avoid problems in completing trials often seen after approval